Aadi Bioscience Performance

AADIDelisted Stock  USD 2.02  0.25  14.12%   
The firm shows a Beta (market volatility) of 0.0875, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Aadi Bioscience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aadi Bioscience is expected to be smaller as well. Aadi Bioscience right now shows a risk of 0.0%. Please confirm Aadi Bioscience potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Aadi Bioscience will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Aadi Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Aadi Bioscience is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
  

Aadi Bioscience Relative Risk vs. Return Landscape

If you would invest  202.00  in Aadi Bioscience on November 20, 2025 and sell it today you would earn a total of  0.00  from holding Aadi Bioscience or generate 0.0% return on investment over 90 days. Aadi Bioscience is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aadi, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Aadi Bioscience Target Price Odds to finish over Current Price

The tendency of Aadi Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.02 90 days 2.02 
under 95
Based on a normal probability distribution, the odds of Aadi Bioscience to move above the current price in 90 days from now is under 95 (This Aadi Bioscience probability density function shows the probability of Aadi Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Aadi Bioscience has a beta of 0.0875. This suggests as returns on the market go up, Aadi Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Aadi Bioscience will be expected to be much smaller as well. Additionally Aadi Bioscience has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Aadi Bioscience Price Density   
       Price  

Predictive Modules for Aadi Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aadi Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aadi Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.022.022.02
Details
Intrinsic
Valuation
LowRealHigh
1.921.922.22
Details
Naive
Forecast
LowNextHigh
2.142.142.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.702.013.32
Details

Aadi Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Aadi Bioscience is not an exception. The market had few large corrections towards the Aadi Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aadi Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aadi Bioscience within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.05
β
Beta against Dow Jones0.09
σ
Overall volatility
0.44
Ir
Information ratio -0.01

Aadi Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aadi Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aadi Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Aadi Bioscience is now traded under the symbol WHWK. Please update your portfolios or report it if you believe this is an error. Report It!
Aadi Bioscience is not yet fully synchronised with the market data
Aadi Bioscience has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (27.54 M).
Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Aadi Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aadi Stock often depends not only on the future outlook of the current and potential Aadi Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aadi Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding26.9 M
Cash And Short Term Investments108.8 M

Aadi Bioscience Fundamentals Growth

Aadi Stock prices reflect investors' perceptions of the future prospects and financial health of Aadi Bioscience, and Aadi Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aadi Stock performance.

About Aadi Bioscience Performance

By evaluating Aadi Bioscience's fundamental ratios, stakeholders can gain valuable insights into Aadi Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aadi Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aadi Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.

Things to note about Aadi Bioscience performance evaluation

Checking the ongoing alerts about Aadi Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aadi Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Aadi Bioscience is now traded under the symbol WHWK. Please update your portfolios or report it if you believe this is an error. Report It!
Aadi Bioscience is not yet fully synchronised with the market data
Aadi Bioscience has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (27.54 M).
Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Aadi Bioscience's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Aadi Bioscience's stock performance include:
  • Analyzing Aadi Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aadi Bioscience's stock is overvalued or undervalued compared to its peers.
  • Examining Aadi Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Aadi Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aadi Bioscience's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Aadi Bioscience's stock. These opinions can provide insight into Aadi Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Aadi Bioscience's stock performance is not an exact science, and many factors can impact Aadi Bioscience's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Aadi Stock

If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins